Literature DB >> 7873727

Pregnancy outcome and its relationship to progression of renal failure in autosomal dominant polycystic kidney disease.

A B Chapman1, A M Johnson, P A Gabow.   

Abstract

The effect of pregnancy on renal disease has not been defined in autosomal dominant polycystic kidney disease (ADPKD). Therefore, fetal and maternal complication rates in ADPKD women as compared with those in unaffected family members (NADPKD) were assessed. Two hundred thirty-five ADPKD and 108 NADPKD women with 605 and 244 pregnancies, respectively, were studied. Overall, fetal complication rates were similar between ADPKD and NADPKD women (32.6 versus 26.2%). Fetal complications were more common in ADPKD women when they were older than 30 yr. Increased fetal prematurity rates were found in preeclamptic ADPKD women as compared with normotensive ADPKD women (28 versus 10%; P < 0.01). More maternal complications occurred in ADPKD as compared with NADPKD women (35 versus 19%; P < 0.001), with preexisting hypertension being the most important risk factor for a maternal complication to occur. Normotensive ADPKD women who developed preeclampsia were more likely to develop chronic hypertension as compared with those without preeclampsia (89 versus 58%; P < 0.01). Hypertensive ADPKD women with four or more pregnancies had lower creatinine clearances than age-adjusted hypertensive ADPKD women with fewer than four pregnancies (49 +/- 5 versus 66 +/- 3 mL/min per 1.73 m2; P < 0.01). Therefore, normotensive ADPKD women usually have successful, uncomplicated pregnancies. However, hypertensive ADPKD women are at high risk for fetal and maternal complications and measures should be taken to prevent the development of preeclampsia in these women.

Entities:  

Mesh:

Year:  1994        PMID: 7873727     DOI: 10.1681/ASN.V551178

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  17 in total

Review 1.  [Pregnancy and kidney diseases].

Authors:  M Siekierka-Harreis; L C Rump
Journal:  Internist (Berl)       Date:  2011-10       Impact factor: 0.743

2.  Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.

Authors:  Arlene B Chapman; Olivier Devuyst; Kai-Uwe Eckardt; Ron T Gansevoort; Tess Harris; Shigeo Horie; Bertram L Kasiske; Dwight Odland; York Pei; Ronald D Perrone; Yves Pirson; Robert W Schrier; Roser Torra; Vicente E Torres; Terry Watnick; David C Wheeler
Journal:  Kidney Int       Date:  2015-03-18       Impact factor: 10.612

3.  Pregnancy outcomes in autosomal dominant polycystic kidney disease: a case-control study.

Authors:  Min Wu; Diping Wang; Ladan Zand; Peter C Harris; Wendy M White; Vesna D Garovic; Cindy A Kermott
Journal:  J Matern Fetal Neonatal Med       Date:  2015-03-10

Review 4.  Predictors of autosomal dominant polycystic kidney disease progression.

Authors:  Robert W Schrier; Godela Brosnahan; Melissa A Cadnapaphornchai; Michel Chonchol; Keith Friend; Berenice Gitomer; Sandro Rossetti
Journal:  J Am Soc Nephrol       Date:  2014-06-12       Impact factor: 10.121

Review 5.  Stage 1 chronic kidney disease in pregnancy.

Authors:  Tiina Podymow; Phyllis August
Journal:  Obstet Med       Date:  2012-09-17

6.  Pregnancy outcomes after kidney donation.

Authors:  H N Ibrahim; S K Akkina; E Leister; K Gillingham; G Cordner; H Guo; R Bailey; T Rogers; A J Matas
Journal:  Am J Transplant       Date:  2009-04       Impact factor: 8.086

7.  Pregnancy in autosomal recessive polycystic kidney disease.

Authors:  Nicole Banks; Joy Bryant; Roxanne Fischer; Marjan Huizing; William A Gahl; Meral Gunay-Aygun
Journal:  Arch Gynecol Obstet       Date:  2014-09-12       Impact factor: 2.344

Review 8.  Pregnancy management and outcome in women with chronic kidney disease.

Authors:  E Bili; D Tsolakidis; S Stangou; B Tarlatzis
Journal:  Hippokratia       Date:  2013-04       Impact factor: 0.471

Review 9.  Reproductive health and pregnancy in women with chronic kidney disease.

Authors:  Kate S Wiles; Catherine Nelson-Piercy; Kate Bramham
Journal:  Nat Rev Nephrol       Date:  2018-01-22       Impact factor: 28.314

10.  Elamipretide treatment during pregnancy ameliorates the progression of polycystic kidney disease in maternal and neonatal mice with PKD1 mutations.

Authors:  Nastaran Daneshgar; Peir-In Liang; Renny S Lan; McKenna M Horstmann; Lindsay Pack; Gourav Bhardwaj; Christie M Penniman; Brian T O'Neill; Dao-Fu Dai
Journal:  Kidney Int       Date:  2021-12-22       Impact factor: 18.998

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.